Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tulane U. investigates GHRH agonists

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Immunex issued first patent on blood stem cell factor

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Bristol-Myers sets up program for heart attack prevention

Sep. 20, 1996

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Prevention of bone loss with alendronate

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...